Health Care Reform

Artificial intelligence could do more harm than good without careful oversight, according to the Senate Finance Committee, which met to address how to prevent algorithmic bias and unfair care denials by health plans.

The CEOs of Merck, Bristol Myers Squibb and Johnson & Johnson faced a barrage of questions on Capitol Hill from Sen. Bernie Sanders (I-VT) and other members of the Health, Education, Labor and Pensions committee.

Last year, lawmakers in 29 states considered some 90 bills that would regulate quicker response times from insurers, according to the American Medical Association, with victories in New Jersey and Washington, D.C.

Benefits professionals have really pushed against and refuse to follow the status quo this year. It has inspired others to question if following the…

The Delinking Revenue from Unfair Gouging (DRUG) Act would require pharmacy benefit managers that contract with a carrier offering federal health benefits plans to "de-link" the fees they charge insurers from the price of drugs.  

Only about 3 in 10 believe the quality of care and services they receive reflect their costs.